Phage Abp1 Rescues Human Cells and Mice from Infection by Pan-Drug Resistant Acinetobacter Baumannii
Author(s) -
Supeng Yin,
Guangtao Huang,
Yulong Zhang,
Bei Jiang,
Zichen Yang,
Zhi-Wei Dong,
Bo You,
Zhiqiang Yuan,
Fuquan Hu,
Yan Zhao,
Yizhi Peng
Publication year - 2017
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000486117
Subject(s) - acinetobacter baumannii , hela , microbiology and biotechnology , cytotoxicity , phage therapy , bacteriophage , drug , lysogenic cycle , drug resistance , biology , virology , chemistry , bacteria , cell , in vitro , escherichia coli , pharmacology , pseudomonas aeruginosa , biochemistry , genetics , gene
As an "ESKAPE" pathogen, Acinetobacter baumannii is one of the leading causes of drug-resistant infections in humans. Phage therapy may be a useful strategy in treating infections caused by drug-resistant A. baumannii. Among 21 phage strains that were isolated and described earlier, we investigated the therapeutic efficacy of Abp1 because of its relatively wide host range.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom